Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.69%
1,083.98
-7.53
-0.69%
1,091.511,090.401,090.401,081.97
SIXC
Communications
SIXC
Communications
SIXC
-0.02%
609.96
-0.15
-0.02%
610.11610.11610.29606.17
SIXE
Energy
SIXE
Energy
SIXE
+0.21%
1,240.56
+2.58
+0.21%
1,237.981,237.831,245.341,225.03
SIXI
Industrials
SIXI
Industrials
SIXI
-0.37%
1,737.79
-6.49
-0.37%
1,744.711,740.951,747.291,735.64
SIXM
Financials
SIXM
Financials
SIXM
+0.08%
640.71
+0.53
+0.08%
640.18639.92643.19636.70
SIXR
Staples
SIXR
Staples
SIXR
-0.10%
848.71
-0.87
-0.10%
849.58845.27851.68841.28
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.08%
217.66
+0.18
+0.08%
217.48217.48218.16216.39
SIXT
Technology
SIXT
Technology
SIXT
+0.42%
3,274.34
+13.65
+0.42%
3,260.693,273.363,287.813,269.07
SIXU
Utilities
SIXU
Utilities
SIXU
+0.20%
944.32
+1.87
+0.20%
942.45939.39948.80934.04
SIXV
Health care
SIXV
Health care
SIXV
-0.29%
1,462.54
-4.26
-0.29%
1,466.801,464.701,467.191,458.68
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.18%
2,401.63
+4.13
+0.18%
2,397.502,395.032,412.012,391.98
MMQ0:FRA
Definium Therapeutics Inc
€18.15
+5.52%
(+0.95) 1D
May 4, 8:21:13 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MMQ0...
Open
€18.15
High
€18.15
Low
€18.15
Mkt. cap
2.38B
Avg. vol.
257.00
Volume
0.00
52-wk high
€23.00
52-wk low
€12.81
No. of employees
106
News stories
From sources across the web
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.36M
29.81M
30.98M
33.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.80M
11.09M
14.69M
14.06M
Operating expense
32.16M
40.90M
45.67M
47.58M
Total operating expenses
32.16M
40.90M
45.67M
47.58M
Operating income
-32.16M
-40.90M
-45.67M
-47.58M
Other non operating income
7.00M
-2.23M
-22.54M
-5.06M
EBT including unusual items
-23.35M
-42.74M
-67.26M
-50.44M
EBT excluding unusual items
-23.35M
-42.74M
-67.26M
-50.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.35M
-42.74M
-67.26M
-50.44M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.50
-0.78
-
Interest and investment income
2.43M
2.77M
2.26M
3.49M
Interest expense
-602.00K
-2.34M
-1.27M
-1.27M
Net interest expenses
1.83M
436.00K
988.00K
2.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-32.15M
-40.90M
-45.66M
-47.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more